Evaluating Immunogenicity of a Birth Dose of HBV Vaccine in the DRC
NCT03897946
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
569
Enrollment
OTHER
Sponsor class
Conditions
Hepatitis B
Interventions
BIOLOGICAL:
Birth dose hepatitis B vaccine
Sponsor
University of North Carolina, Chapel Hill
Collaborators
[object Object]
[object Object]